Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target
Abstract Diffuse large B-cell lymphoma (DLBC) is the most common subtype of non-Hodgkin lymphoma, characterized by its aggressive nature and poor prognosis in advanced stages. Despite advances in treatment, the molecular mechanisms driving DLBC progression remain incompletely understood, necessitati...
Saved in:
| Main Authors: | Junaid Abid, Mahmood Basil A. Al-Rawi, Ahmad Mahmood, An Li, Tiemin Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-025-00411-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Céline, du Styx au Léthé
by: Frédéric Saenen
Published: (2019-06-01) -
The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets
by: Qinghong Yuan, et al.
Published: (2025-06-01) -
BEND4: a novel prognostic biomarker in diffuse large B-cell lymphoma
by: Yanfang Wang, et al.
Published: (2025-05-01) -
NOS2 as a prognostic biomarker for early-onset colorectal cancer based on public data and clinical validation analysis
by: Chaoqun Xing, et al.
Published: (2025-02-01) -
Comprehensive analysis of SELPLG as a potential immunotherapy target and prognostic biomarker in oncology
by: Ranran Shi, et al.
Published: (2025-06-01)